Skip to main content
Taylor & Francis Group Logo
    Advanced Search

    Click here to search products using title name,author name and keywords.

    • Login
    • Hi, User  
      • Your Account
      • Logout
      Advanced Search

      Click here to search products using title name,author name and keywords.

      Breadcrumbs Section. Click here to navigate to respective pages.

      Chapter

      Management of fetal anomalies
      loading

      Chapter

      Management of fetal anomalies

      DOI link for Management of fetal anomalies

      Management of fetal anomalies book

      Management of fetal anomalies

      DOI link for Management of fetal anomalies

      Management of fetal anomalies book

      ByMichele P Mohajer
      BookObstetrics & Gynaecology

      Click here to navigate to parent product.

      Edition 3rd Edition
      First Published 2016
      Imprint CRC Press
      Pages 4
      eBook ISBN 9780429162398
      Share
      Share

      ABSTRACT

      The management of the pregnancy in which an abnormal fetus is identified involves a whole multidisciplinary team of specialists. This team comprises the sonographer, fetal medicine specialist, geneticist, neonatologist and paediatric surgeon, along with the nurse specialists within each team. Parents may find the prospect of a postmortem examination of their baby very distressing, but it is a vital part of the management. When parents are told of a fetal abnormality, they must make decisions, the most important being whether to continue or terminate the pregnancy. Management of continuing pregnancies includes communication between hospital and community health workers, continuity of care with the same personnel, adequate time and repeated counselling, written information and contacts with support groups. Fetal sedation may be necessary prior to the fetocide. This is achieved by the administration of diazepam or pethidine into the fetal circulation. An ultrasound should be performed hour after the injection of potassium chloride to ensure cessation of fetal heart pulsation.

      T&F logoTaylor & Francis Group logo
      • Policies
        • Privacy Policy
        • Terms & Conditions
        • Cookie Policy
        • Privacy Policy
        • Terms & Conditions
        • Cookie Policy
      • Journals
        • Taylor & Francis Online
        • CogentOA
        • Taylor & Francis Online
        • CogentOA
      • Corporate
        • Taylor & Francis Group
        • Taylor & Francis Group
        • Taylor & Francis Group
        • Taylor & Francis Group
      • Help & Contact
        • Students/Researchers
        • Librarians/Institutions
        • Students/Researchers
        • Librarians/Institutions
      • Connect with us

      Connect with us

      Registered in England & Wales No. 3099067
      5 Howick Place | London | SW1P 1WG © 2022 Informa UK Limited